Has This Once-Hot Med Tech Innovation Flatlined?

The medical device industry relies on new technologies to keep cutting-edge companies and stocks soaring, and few innovations have set the industry alight recently like promising high blood pressure treatment renal denervation. Analysts have pegged this growing market's worth at up to $1.5 billion by 2020, and companies from Boston Scientific  (NYSE: BSX  )  to Medtronic  (NYSE: MDT  )  have invested heavily to score positive results and capture dominance in this up-and-coming niche.

Not so fast: Medtronic's been one of the biggest players in the renal denervation race, but a recent study slammed the brakes on the industry's optimism. This past weekend, Medtronic revealed the results of a renal denervation clinical trial failure it first announced back in January, and by an effectiveness standard, the data's not promising for the leading cardiac device makers in the med tech field.

Will this failure shake up your portfolio's outlook? In the video below, find out all about Medtronic's renal denervation blemish and what it means to this once-promising med tech field as Motley Fool contributor Dan Carroll takes you through the key details that could put a quick halt to this niche's lofty expectations.

Can med tech make you rich in 2014?
There's still time for leading medical device stocks such as Boston Scientific and Medtronic to hit their stride this year, but there's one truth that the best investors know: There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2899923, ~/Articles/ArticleHandler.aspx, 9/30/2014 8:27:46 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 17,042.90 -28.32 -0.17%
S&P 500 1,972.29 -5.51 -0.28%
NASD 4,493.39 -12.46 -0.28%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2014 4:00 PM
BSX $11.81 Down -0.11 -0.92%
Boston Scientific… CAPS Rating: **
MDT $61.95 Down -0.59 -0.94%
Medtronic CAPS Rating: *****
COV $86.51 Down -1.30 -1.48%
Covidien CAPS Rating: *****
STJ $60.13 Down -1.01 -1.65%
St. Jude Medical,… CAPS Rating: ****

Advertisement